Target Audience:
Clinicians and scientists interested in Cryptococcus and Cryptococcosis

Educational Needs Addressed:
Infections due to Cryptococcus cause significant health problems worldwide, particularly in those individuals that have weakened immune systems. This conference is an opportunity for scientists and clinicians to discuss the latest advances in the ecology and molecular biology of the fungus, the immunology of the host response to the fungus, and therapy for this deadly disease.

Educational Objectives:
1) Understanding the protean manifestations of Cryptococcosis in both immunocompromised and immonacompetent patients and the many therapeutic options for treatment of Cryptococcosis.

2) Advanced knowledge of the epidemiology of Cryptococcosis and the biology of Cyrptococcus, particularly on recent insights gained from the genome sequencing project.

3) Familiarity with the host immune response to the fungus, both in humans and in experimental animal models, and the mechanisms by which fungal virulence factors operate.

Accreditation:
This meeting is being accredited by the Boston University School of Medicine.

Boston University School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Boston University School of Medicine designates this educational activity for hour-for-hour Category 1 credit towards the AMA Physician's Recognition Award. Each physician should claim only those hours that he/she actually spent in the activity.

The American Medical Association has determined that physicians not licensed in the US who participate in this CME activity are eligible for AMA PRA category 1 credit.